Hospira (HSP) reports disappointing fourth quarter results. Revenue of $992M was 5% short...
Hospira (HSP) reports disappointing fourth quarter results. Revenue of $992M was 5% short of estimates, while the bottom line missed by $0.16. Results were hampered discontinuations, shipment holds, operational inefficiencies and a litany of charges.
Check out Seeking Alpha’s new Earnings Center »
From other sites
at Nasdaq.com (Wed, 11:30AM)
at Zacks.com (Apr 8, 2015)
at MarketWatch.com (Feb 12, 2015)
at Benzinga.com (Feb 12, 2015)
at MarketWatch.com (Feb 10, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs